Capecitabine Tablets Manufacturers PAN India, Suppliers

Taj Pharma – Leading Manufacturer & Exporter of Capecitabine Tablets 150mg (Xlotabin) from India

Taj Pharma India is a globally recognized name in the pharmaceutical industry, specializing in high-quality, oncology medications. Among our flagship products is Capecitabine Tablets 150mg (marketed under the brand name Xlotabin), a vital oral chemotherapy agent used in the treatment of colorectal and breast cancers. Based in Vapi, Gujarat, and with pan-India and international distribution capabilities, Taj Pharmaceuticals Ltd is setting new benchmarks in cancer care with precision, quality, and affordability.


What is Capecitabine Tablets 150mg (Xlotabin)?

Capecitabine is a prodrug of 5-fluorouracil (5-FU), which means it becomes active only after being metabolized in the body. Once ingested, it is converted into 5-FU by tumor cells, where it inhibits DNA and RNA synthesis—ultimately killing cancerous cells and slowing down the progression of disease. The 150mg dosage is frequently prescribed in conjunction with other chemotherapeutic agents or as monotherapy, especially in early or advanced-stage colorectal and breast cancers.


Why Taj Pharma is the Most Trusted Capecitabine 150mg Tablet Manufacturer in India

At Taj Pharma, we understand the responsibility that comes with manufacturing oncology medicines. As a WHO-GMP, EU-GMP, and ISO-certified pharmaceutical company, we follow the highest standards of quality control, purity, and consistency. Our Vapi-based manufacturing facility ensures seamless production under strict regulatory norms, offering assurance and reliability to healthcare providers and patients alike.

Key Strengths:

  • PAN India Capecitabine Supply Network
  • Exports to over 75 countries including Africa, LATAM, and the Middle East
  • PCD Pharma Franchise opportunities across India
  • Affordable pricing for large-scale hospital supply contracts
  • Dedicated Oncology Division with 200+ specialized products

Capecitabine Tablets 150mg (Xlotabin) – Technical Specifications

ParameterSpecification
Product NameCapecitabine Tablets 150mg (Xlotabin)
Active IngredientCapecitabine USP
Dosage FormFilm-coated oral tablets
Strength150 mg
Route of AdministrationOral
PackagingAlu-Alu / Blister packs
Shelf Life24–36 months
Regulatory DocumentsWHO-GMP, COPP, FSC, COA, MSDS
Therapeutic UseAntineoplastic (chemotherapy)
IndicationBreast cancer, Colorectal cancer
Storage ConditionsStore below 30°C in a dry, dark place
Market AvailabilityIndia + Global Export

Applications: Capecitabine Tablets for Cancer Treatment

1. Colorectal Cancer

Capecitabine is often first-line therapy for metastatic colorectal cancer (CRC) and is used either alone or in combination with oxaliplatin (CAPOX). Patients benefit from the oral administration, which eliminates the need for intravenous infusions and improves compliance.

2. Breast Cancer

For locally advanced or metastatic breast cancer, particularly in women who have failed anthracycline-containing regimens, Capecitabine is a proven therapy that delivers favorable response rates and quality of life improvements.


Dosage and Administration Guidelines

Capecitabine should be taken within 30 minutes after a meal to maximize absorption. The standard dosage varies based on body surface area and whether it is used as a monotherapy or in combination therapy. It is usually taken twice a day for 14 days followed by a 7-day rest period. Duration and cycles depend on the type and stage of cancer.

Note: Dosing must be customized based on patient renal function and liver condition. Always follow the oncologist’s guidance.


Why Choose Taj Pharma for Capecitabine Tablets?

1. Unmatched Quality Control

Every batch undergoes rigorous quality assurance testing, including:

  • HPLC Assay & Purity Testing
  • Dissolution and Disintegration Tests
  • Microbial Testing & Stability Analysis

2. Compliance with International Standards

Our manufacturing unit is approved by major regulatory bodies such as:

  • WHO-GMP
  • EU-GMP
  • PICS
  • NAFDAC
  • MOH (Various Countries)

3. Rapid & Reliable Global Logistics

We cater to bulk procurement needs of government health ministries, oncology hospitals, and distributors, providing:

  • Swift order processing
  • Custom packaging solutions
  • Documentation for easy import/export clearance

4. PCD Franchise and Contract Manufacturing

Taj Pharma also offers lucrative PCD pharma franchise models and third-party manufacturing of Capecitabine Tablets across India with marketing support, monopoly rights, and competitive pricing.


Capecitabine Tablets – PAN India & Global Supply Network

We are proud to serve leading oncology centers, cancer hospitals, and government tenders across the following markets:

  • India: Mumbai, Delhi, Ahmedabad, Chennai, Hyderabad, Kolkata
  • Africa: Nigeria, Kenya, Ghana, South Africa, Ethiopia
  • LATAM: Brazil, Argentina, Colombia, Peru
  • Middle East: UAE, Saudi Arabia, Jordan, Iraq, Egypt

Capecitabine Tablets 150mg (Xlotabin) Price & Packaging

Our pricing is among the most affordable in India, thanks to vertical integration of raw materials and streamlined production. We offer:

  • Competitive rates for bulk hospital purchases
  • Custom blister/Alu-Alu packaging with branding options
  • Contract pricing for NGOs and cancer foundations

Taj Pharma’s Commitment to Oncology Patients

We are not just manufacturers—we are catalysts in the global fight against cancer. With Capecitabine 150mg (Xlotabin), we offer more than just a product; we offer a promise of affordability, accessibility, and efficacy. Our aim is to empower oncologists with dependable therapies and give patients a fair chance at life.


Get in Touch – Capecitabine 150mg (Xlotabin) Manufacturer India

If you are a hospital procurement officer, pharma distributor, or franchise seeker, Taj Pharma invites you to join hands and bring cutting-edge oncology care to every corner of the world.

📞 Call/WhatsApp: +91 84484 44095
📧 Email: info@tajpharma.com
🌐 Website: www.tajpharma.com
📍 Manufacturing Unit: Vapi, Gujarat, India